Results 251 to 260 of about 225,959 (356)

Potential of Eugenia brejoensis (Mazine) Essential Oil in Combating Multidrug‐Resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa

open access: yesChemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT The genus Eugenia has a long history of use in traditional medicine for treating various conditions, including infectious diseases, gastrointestinal disorders, and skin problems. Essential oils derived from Eugenia species are known for their medicinal properties and have been studied for their antimicrobial and bioactive potential. This study
Jonathan Mandú de Araújo   +10 more
wiley   +1 more source

Inference of antimicrobial resistance (AMR) from a whole genome database outperforming AMR gene detection. [PDF]

open access: yesiScience
Cholsaktrakool P   +15 more
europepmc   +1 more source

Exploiting Pharmacokinetic/Pharmacodynamic Methods for Optimizing and Accelerating Drug Development of Innovative Anti‐Infectives

open access: yesChemMedChem, Volume 21, Issue 2, January 2026.
This article focuses on the interplay of absorbed, distributed, metabolized, and excreted (ADME) properties; in vivo pharmacokinetics (PK); and pharmacodynamics (PD) supported by in silico PK/PD modeling techniques to improve drug development by acceleration of processes and reducing attrition risks.
Katharina Rox
wiley   +1 more source

Food Safety in the Catering Sector: Nonconformities, Challenges, and Strategic Interventions With Insights From South Asia and Africa

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
Urgent attention to global food safety in catering is necessary to address hygiene, training, and tech‐based strategies to counter foodborne diseases. ABSTRACT Food safety in the catering sector is an essential public health issue, as foodborne diseases (FBDs) continue to pose significant threats worldwide.
Anwar Ali   +7 more
wiley   +1 more source

Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to Action. [PDF]

open access: yesInfect Dis Ther
Bassetti M   +14 more
europepmc   +1 more source

Clinical Safety and Tolerability of Bifidobacterium bifidum BBi32: An 8‐Week Randomized, Double‐Blind, Placebo‐Controlled Trial With Genomic and In Vitro Corroboration

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
An 8‐week randomized, double‐blind, placebo‐controlled trial found BBi32 well tolerated with no hematologic or hepatic abnormalities. Versus placebo, BBi32 reduced uric acid/urea/creatinine, increased LL‐37, and lowered gastrointestinal symptom scores.
Shuguang Fang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy